Carboxamides and hydrazide of glycopeptide antibiotic eremomycin synthesis and antibacterial activity

A. Y. Pavlov, T. F. Berdnikova, E. N. Olsufyeva, O. V. Miroshnikova, S. T. Filipposyanz, M. N. Preobrazhenskaya, C. Sottani, L. Colombo, B. P. Goldstein

Research output: Contribution to journalArticle

Abstract

Carboxamides and hydrazide of glycopeptide antibiotic eremomycin were obtained by a direct reaction of the carboxy group of eremomycin with an appropriate amine or hydrazine using diphenyl phosphorazidate as a condencing agent. Eremomycin hydrazide was also obtained by hydrazinolysis of the eremomycin methyl ester. Use of dicyclohexylcarbodiimide or 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide for amidation led to the corresponding eremomycin ureides. The ESI-MS data indicate that eremomycin and its amides exist as dimers. The carboxamide, methylamide and benzylamide of eremomycin were as active against Gram-positive bacteria as the parent antibiotic, and the methylamide, benzylamide and hydrazide were almost an order of magnitude more active than eremomycin against Staphylococcus epidermidis clinical isolates ill vitro. Amide of eremomycin as well as ureides were devoid of histamine liberating properties, which demonstrates that protection of the carboxyl group leads to a decrease in the allergenic properties.

Original languageEnglish
Pages (from-to)194-198
Number of pages5
JournalJournal of Antibiotics
Volume49
Issue number2
Publication statusPublished - Feb 1996

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Fingerprint Dive into the research topics of 'Carboxamides and hydrazide of glycopeptide antibiotic eremomycin synthesis and antibacterial activity'. Together they form a unique fingerprint.

  • Cite this

    Pavlov, A. Y., Berdnikova, T. F., Olsufyeva, E. N., Miroshnikova, O. V., Filipposyanz, S. T., Preobrazhenskaya, M. N., Sottani, C., Colombo, L., & Goldstein, B. P. (1996). Carboxamides and hydrazide of glycopeptide antibiotic eremomycin synthesis and antibacterial activity. Journal of Antibiotics, 49(2), 194-198.